Report Detail
Global Pertussis Vaccine Market Insights, Forecast to 2025
- RnM2937044 |
- 13 February, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
Manufacturers take the combination of direct Marketing channel and distribution sales in the form, Future sales channels both direct selling and distribution needs with the help of online sales platform.
The market channel is essential to every manufacturer and they are paying more and more attention to their channel building. Firstly, suppliers can build strong sales teams to directly manage their own customers. At the same time, more flexible and attractive channel incentives can be created and channel support can be provided in different ways. At the meantime, customers are concerning more on the product quality and services. So, except all of the distributors and direct marketing, they are also consider their logistics and services, making sure that both products and services are better than the competitors.
Depending on market position, make different pricing strategy. Pricing product is based on product position. Different kind of dispensers should be priced differently. It is obvious that high-end product should be expensive and low-end product should be cheap.
For the manufacturers, depreciate can bring more consumers and inflation can bring larger profit margin. When manufacturers price their products, should consider many factors like the manufacturing cost, market position and targets of price adjustment (larger profit margin, more consumers, larger market share, more order, etc.).
To build a brand admired by consumers need a long time, though the period is much shorter due to the development of advertising industry and internet. There are many ways to build a new brand, but only one way is always here, good product quality.
Today, brand strategy has been various. Some manufacturers hold their unique brand, which have been acquired by consumers. Exactly, consumers may prefer the known brand rather a new brand that they doesn’t know. On the contrary, some manufacturers may introduce several brands of their product. They featured each brand and market them for certain target client.
The global Pertussis Vaccine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Pertussis Vaccine market based on company, product type, end user and key regions.
This report studies the global market size of Pertussis Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pertussis Vaccine in these regions.
This research report categorizes the global Pertussis Vaccine market by top players/brands, region, type and end user. This report also studies the global Pertussis Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
Astellas Pharma
Minhai Biotechnology
Wuhan Institute of Biological Products
Changchun Changsheng Life Sciences
Market size by Product
Whole-cell vaccines
Acellular vaccines
Market size by End User
Children
Adults
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Pertussis Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Pertussis Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Pertussis Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Pertussis Vaccine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Pertussis Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pertussis Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Pertussis Vaccine Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Pertussis Vaccine Market Size Growth Rate by Product
- 1.4.2 Whole-cell vaccines
- 1.4.3 Acellular vaccines
- 1.5 Market by End User
- 1.5.1 Global Pertussis Vaccine Market Size Growth Rate by End User
- 1.5.2 Children
- 1.5.3 Adults
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Pertussis Vaccine Market Size
- 2.1.1 Global Pertussis Vaccine Revenue 2014-2025
- 2.1.2 Global Pertussis Vaccine Sales 2014-2025
- 2.2 Pertussis Vaccine Growth Rate by Regions
- 2.2.1 Global Pertussis Vaccine Sales by Regions
- 2.2.2 Global Pertussis Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Pertussis Vaccine Sales by Manufacturers
- 3.1.1 Pertussis Vaccine Sales by Manufacturers
- 3.1.2 Pertussis Vaccine Sales Market Share by Manufacturers
- 3.1.3 Global Pertussis Vaccine Market Concentration Ratio (CR5 and HHI)
- 3.2 Pertussis Vaccine Revenue by Manufacturers
- 3.2.1 Pertussis Vaccine Revenue by Manufacturers (2014-2019)
- 3.2.2 Pertussis Vaccine Revenue Share by Manufacturers (2014-2019)
- 3.3 Pertussis Vaccine Price by Manufacturers
- 3.4 Pertussis Vaccine Manufacturing Base Distribution, Product Types
- 3.4.1 Pertussis Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Pertussis Vaccine Product Type
- 3.4.3 Date of International Manufacturers Enter into Pertussis Vaccine Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Pertussis Vaccine Sales by Product
- 4.2 Global Pertussis Vaccine Revenue by Product
- 4.3 Pertussis Vaccine Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Pertussis Vaccine Breakdown Data by End User
6 North America
- 6.1 North America Pertussis Vaccine by Countries
- 6.1.1 North America Pertussis Vaccine Sales by Countries
- 6.1.2 North America Pertussis Vaccine Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Pertussis Vaccine by Product
- 6.3 North America Pertussis Vaccine by End User
7 Europe
- 7.1 Europe Pertussis Vaccine by Countries
- 7.1.1 Europe Pertussis Vaccine Sales by Countries
- 7.1.2 Europe Pertussis Vaccine Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Pertussis Vaccine by Product
- 7.3 Europe Pertussis Vaccine by End User
8 Asia Pacific
- 8.1 Asia Pacific Pertussis Vaccine by Countries
- 8.1.1 Asia Pacific Pertussis Vaccine Sales by Countries
- 8.1.2 Asia Pacific Pertussis Vaccine Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Pertussis Vaccine by Product
- 8.3 Asia Pacific Pertussis Vaccine by End User
9 Central & South America
- 9.1 Central & South America Pertussis Vaccine by Countries
- 9.1.1 Central & South America Pertussis Vaccine Sales by Countries
- 9.1.2 Central & South America Pertussis Vaccine Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Pertussis Vaccine by Product
- 9.3 Central & South America Pertussis Vaccine by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Pertussis Vaccine by Countries
- 10.1.1 Middle East and Africa Pertussis Vaccine Sales by Countries
- 10.1.2 Middle East and Africa Pertussis Vaccine Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Pertussis Vaccine by Product
- 10.3 Middle East and Africa Pertussis Vaccine by End User
11 Company Profiles
- 11.1 Sanofi Pasteur
- 11.1.1 Sanofi Pasteur Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Sanofi Pasteur Pertussis Vaccine Products Offered
- 11.1.5 Sanofi Pasteur Recent Development
- 11.2 GSK
- 11.2.1 GSK Company Details
- 11.2.2 Company Business Overview
- 11.2.3 GSK Pertussis Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 GSK Pertussis Vaccine Products Offered
- 11.2.5 GSK Recent Development
- 11.3 Mitsubishi Tanabe Pharma
- 11.3.1 Mitsubishi Tanabe Pharma Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Products Offered
- 11.3.5 Mitsubishi Tanabe Pharma Recent Development
- 11.4 Astellas Pharma
- 11.4.1 Astellas Pharma Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Astellas Pharma Pertussis Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Astellas Pharma Pertussis Vaccine Products Offered
- 11.4.5 Astellas Pharma Recent Development
- 11.5 Minhai Biotechnology
- 11.5.1 Minhai Biotechnology Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Minhai Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Minhai Biotechnology Pertussis Vaccine Products Offered
- 11.5.5 Minhai Biotechnology Recent Development
- 11.6 Wuhan Institute of Biological Products
- 11.6.1 Wuhan Institute of Biological Products Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Wuhan Institute of Biological Products Pertussis Vaccine Products Offered
- 11.6.5 Wuhan Institute of Biological Products Recent Development
- 11.7 Changchun Changsheng Life Sciences
- 11.7.1 Changchun Changsheng Life Sciences Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Changchun Changsheng Life Sciences Pertussis Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Changchun Changsheng Life Sciences Pertussis Vaccine Products Offered
- 11.7.5 Changchun Changsheng Life Sciences Recent Development
12 Future Forecast
- 12.1 Pertussis Vaccine Market Forecast by Regions
- 12.1.1 Global Pertussis Vaccine Sales Forecast by Regions 2019-2025
- 12.1.2 Global Pertussis Vaccine Revenue Forecast by Regions 2019-2025
- 12.2 Pertussis Vaccine Market Forecast by Product
- 12.2.1 Global Pertussis Vaccine Sales Forecast by Product 2019-2025
- 12.2.2 Global Pertussis Vaccine Revenue Forecast by Product 2019-2025
- 12.3 Pertussis Vaccine Market Forecast by End User
- 12.4 North America Pertussis Vaccine Forecast
- 12.5 Europe Pertussis Vaccine Forecast
- 12.6 Asia Pacific Pertussis Vaccine Forecast
- 12.7 Central & South America Pertussis Vaccine Forecast
- 12.8 Middle East and Africa Pertussis Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Pertussis Vaccine Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Pertussis Vaccine . Industry analysis & Market Report on Pertussis Vaccine is a syndicated market report, published as Global Pertussis Vaccine Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Pertussis Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
